Introduction Novo Nordisk, a Danish multinational pharmaceutical company, plays a crucial role in the management of diabetes globally. With approximately 537 million adults living with diabetes worldwide according to the International Diabetes Federation, the importance of effective management and treatment options has never been greater. Novo Nordisk’s commitment to research and innovation has positioned it